Importantly, one of the identified TROLLs was MALAT1, previously demonstrated to promote different metastatic tumour types in humans15–17, including breast cancer where high levels of this lncRNA correlate with higher risk of relapse and reduced overall survival18–20. This evidence concerns the gene MALAT1 and breast carcinoma.